Brief: Lavipharm Signs 5-Year Exclusive Cooperation Agreement With Zentiva
Aug 5 (Reuters) - Lavipharm SA LPHr.AT :
* SIGNS 5-YEAR CONTRACT WITH ZENTIVA FOR EXCLUSIVE
REPRESENTATION,
PROMOTION AND DISTRIBUTION OF ITS PHARMACEUTICAL PRODUCTS IN
GREECE
Source text : https://bit.ly/3id27Ng
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY